UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 4.

Harter, P; du Bois, A; Mahner, S; Pfisterer, J; Ortmann, O; Marth, C; Fink, D; Hilpert, F; Wagner, U; Sehouli, J (2016). Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer. Geburtshilfe und Frauenheilkunde, 76(2):147-149.

Mittelbronn, M; Harter, P; Warth, A; Lupescu, A; Schilbach, K; Vollmann, H; Capper, D; Frei, K; Bertalanffy, H; Weller, M; Meyermann, R; Lang, F; Simon, P (2009). EGR-1 is regulated by N-methyl-D-aspartate-receptor stimulation and associated with patient survival in human high grade astrocytomas. Brain Pathology, 19(2):195-204.

Harter, P; Hahmann, M; Lueck, H J; Poelcher, M; Wimberger, P; Ortmann, O; Canzler, U; Richter, B; Wagner, U; Hasenburg, A; Burges, A; Loibl, S; Meier, W; Huober, J; Fink, D; Schroeder, W; Muenstedt, K; Schmalfeldt, B; Emons, G; du Bois, A (2009). Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis. Annals of Surgical Oncology, 16(5):1324-1330.

Fink, D; Schmalenfeldt, B; du Bois, A; Burges, A; Emons, G; Gropp, M; Harter, P; Hasenburg, A; Hauptmann, S; Jäger, W; Kimmig, R; Kommoss, F; Kreienberg, R; Kuhn, W; Meier, W; Münstedt, K; Ortmann, O; Pfisterer, J; Richter, B; Runnebaum, I; Schröder, W; Sehouli, J; Tanner, B; Wagner, U (2008). Aktuelle und zukünftige Entwicklungen in der Diagnostik und Therapie des Ovarialkarzinoms. Geburtshilfe und Frauenheilkunde, 68(4):382-388.

This list was generated on Mon Jul 24 21:53:43 2017 CEST.